Recent news on Daytrana

Daytrana provides significant effectiveness in both boys and girls ...  -  25 May 2007
News-Medical.net,Our study documented that DAYTRANA offered a favorable safety profile and was an effective ADHD treatment in both boys and girls," said Robert Findling, MD,

FDA Approves SPD465 For Treatment Of ADHD In Adults  -  May 21, 2007
eMaxHealth.com,DAYTRANA should not be used in patients with allergy to methylphenidate or patch components; marked anxiety, tension and agitation; glaucoma; tics,

Shire gets approvable letter for ADHD drug  -  May 22, 2007
Phoenix Business Journal,Shire's portfolio of ADHD treatments includes Vyvanse, Daytrana, and Adderall XR. Based in Basingstoke, England, Shire has its US headquarters in Wayne, Pa.

Pay Attention to Noven  -  May 1, 2007
Motley FoolRevenue nearly doubled versus the year-ago period as sales of its attention-deficit hyperactivity disorder patch, Daytrana, began to pick up in the first

Sales Advance at Noven  -  Apr 30, 2007
TheStreet.comNet revenue for the most recent quarter increased 90% to $19.3 million, primarily because of $4.4 million in Daytrana product sales to Shire (SHPGY

Noven Announces 2007 Annual Meeting Results  -  May 18, 2007
InfoBolsa,Noven s prescription patches are approved in over 30 countries and include Vivelle-Dot(R) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Business news in brief  -  Apr 26, 2007
Philadelphia Inquirer,...boosted by sales of the best-selling Adderall XR for attention deficit disorder and new products including Elaprase and the Daytrana patch.

Business news in brief  -  26 Apr 2007
Philadelphia Inquirer,...boosted by sales of the best-selling Adderall XR for attention deficit disorder and new products including Elaprase and the Daytrana patch.

Shire First-Quarter Net Almost Doubles on New Drugs (Update1)  -  Apr 25, 2007
BloombergThe company introduced Lialda -- formerly known as Mesavance -- for ulcerative colitis, Dynepo for anemia and chronic kidney failure, Daytrana and Elaprase

Noven to Present at Deutsche Bank Annual Health Care Conference  -  Apr 25, 2007
Genetic Engineering News (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(R) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Shire plc: First Quarter Results - Strong Start to the Year With ...  -  Apr 25, 2007
Genetic Engineering News (press release),DAYTRANA continues to be well accepted and to gain share. We completed the acquisition of New River Pharmaceuticals Inc. on April 19 , gaining full control

Noven Announces First Quarter 2007 Earnings Release Date  -  Apr 23, 2007
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(R) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Shire Holders Clear Purchase  -  Apr 16, 2007
TheStreet.comShire sells two other ADHD drugs, Adderall XR and Daytrana. It expects to hear from the FDA in the coming months on applications for two others.

Noven Announces 2006 Financial Results  -  Mar 2, 2007
PharmaLive.com (press release),..."Our major achievements in 2006 included the US launch of our Daytrana(TM) methylphenidate transdermal system by Shire plc, the market leader in Attention

Profits rise at Noven for Q4, year  -  Mar 2, 2007
South Florida Business Journal,During the year, Noven launched its Daytrana drug for attention deficit hyperactivity disorder, licensed to Shire PLC. Robert C. Strauss, Noven president,

Noven to Present at Lehman Brothers Global Healthcare Conference  -  Mar 14, 2007
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(R) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Noven Pharma Falls After Solid Results  -  Mar 2, 2007
Forbes,Noven said equity increases in its Novogyne women's health venture with Novartis AG and sales of the attention deficit disorder treatment Daytrana drove

Noven Pharma 4Q Profit Rises  -  Mar 1, 2007
Houston Chronicle,Drug delivery technology company Noven Pharmaceuticals Inc. said Thursday its fourth-quarter profit rose 18 percent on an increase in sales of Daytrana and

Noven Pharma 4Q profit rises  -  Mar 1, 2007
Hemscott,The company also said Daytrana, its skin patch to treat ADHD in children, boosted its results. The treatment -- which received approval from the Food and

Shire's Busy Week  -  Feb 26, 2007
Motley Fool...for nearly half of its revenues, I'm sure Shire will work hard to switch patients over to Vyvanse and its other new ADHD treatments like Daytrana.

ADHD Drug Warnings Come Too Late For Many  -  Mar 11, 2007
Dissident Voice,Daytrana, Desoxyn, Dexedrine, Focalin, Metadate CD, Methylin, Ritalin, Strattera, and the extended-release, patch and chewable versions of these drugs.

CMI KOP Office Realignment Press Release  -  Feb 28, 2007
PharmaLive.com (press release),...assisting Leanne Davis with the work supervision and training of the KOP2 staff and handling planning for all Lilly brands as well as Shire’s Daytrana.

Noven Receives $25 Million Daytrana Sales Milestone  -  Feb 21, 2007
PharmaLive.com (press release),Daytrana(TM), licensed globally to Shire, was launched in June 2006. Payment of the first milestone was triggered upon Shire's net sales of Daytrana(TM)

Shire plc: On Time Execution of Operating Plan Delivers Strong ...  -  Feb 20, 2007
Earthtimes.orgWe will benefit from the recent launches of DAYTRANA(TM) and ELAPRASE(TM) and roll-out of FOSRENOL(R) in Europe and anticipate three additional product

Noven Gets $25M Payment for ADHD Drug  -  Feb 20, 2007
Houston Chronicle,Shire has worldwide rights to sell Daytrana, the first skin patch to treat ADHD in children. Noven developed and makes the treatment, which received

FDA Orders ADHD Drug Guidelines  -  Feb 21, 2007
Post ChronicleThe ADHD medicines include Adderall, Concerta, Daytrana, Desoxyn, Dexedrine, Focalin, Metadate, Methylin, Ritalin, and Strattera. (c) UPI.

Shire acquires New river, in black  -  Feb 20, 2007
ShareCast,Shire has a strong pipeline with the recent launches of Daytrana and Elaprase and roll-out of Fosrenol in Europe and three further product launches during

Biotech Day In Review: Genentech Loses Cabilly Patent Ruling  -  Feb 22, 2007
Seeking Alpha,Noven Pharma (NOVN) received a $25 million sales milestone from Shire (SHPGY) because Daytrana achieved more than $25 million in revenue during 2006.

Shire to target Europe as ADHD market opens up  -  Feb 9, 2007
Reuters...two of its next generation of ADHD treatments, skin patch Daytrana and Vyvanse, a successor to Adderall XR, in Europe in 2008 and 2009 respectively.

Noven to Present at Deutsche Bank Small Cap Growth Conference  -  Feb 7, 2007
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(TM) (the most prescribed estrogen patch in the US) and Daytrana(TM)

SHIRE PLC: Final Results  -  Feb 20, 2007
FinanzNachrichten.de,We will benefit from the recent launches of DAYTRANA™ and ELAPRASE™ and roll-out of FOSRENOL® in Europe and anticipate three additional product launches

Patient Medication Guides for ADHD Drugs  -  Feb 23, 2007
Facts and Comparisons,Adderall, Adderall XR, Concerta, Daytrana, Desoxyn, Dexedrine, Focalin, Focalin XR, Metadate CD, Methylin, Ritalin, Ritalin SR, Ritalin LA,

Noven Announces 2006 Earnings Release Date and Upcoming Investor ...  -  Feb 23, 2007
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(TM) (the most prescribed estrogen patch in the US) and Daytrana(TM)

ADHD Drugs May Pose Serious Health Risks  -  Feb 22, 2007
Fashion Monitor Toronto,The drugs mentioned in the warning include Adderall, Concerta, Daytrana, Dexedrine, Focalin, Metadate, Methylin, Ritalin, and Strattera.

FDA wants clear warnings on ADHD drugs  -  Feb 22, 2007
News-Medical.net,The medications affected by the action include Adderall, Adderall XR, Concerta, Daytrana, Desoxyn, Dexedrine, Focalin, Focalin XR, Metadate CD, Methylin,

FDA: Tell patients about risks of ADHD drugs  -  Feb 22, 2007
Food Consumer,The drugs of concern include Adderall, Adderall XR, Concerta, Daytrana, Desoxyn, Dexedrine, Focalin, Focalin XR, Metadate CD, Methylin, Methylin, Ritalin,

ADHD Drugs Pose Serious Health Risks  -  Feb 22, 2007
Toronto Daily News,The drugs mentioned in the warning include Adderall, Concerta, Daytrana, Dexedrine, Focalin, Metadate, Methylin, Ritalin, and Strattera.

ADHD Drug Makers To Notify Patients About Health Risks  -  Feb 22, 2007
Medical News Today,The new instruction affects 15 products, including various forms of Adderall, Concerta, Daytrana, Dexedrine, Focalin, Metadate, Methylin, Ritalin,

ADHD Drugs to Get New Warnings  -  Feb 21, 2007
Newsinferno.com,There are 15 medications subject to the new warnings: Adderall, Adderall XR, Concerta, Daytrana, Desoxyn, Dexedrine, Focalin, Focalin XR, Metadate CD,

Health Highlights: Feb. 21, 2007  -  Feb 21, 2007
Forbes,The new directive covers all approved ADHD drugs, including: Adderall, Adderall XR, Concerta, Daytrana, Desoxyn, Dexedrine, Focalin, Focalin XR,

Shire buys New River Pharmaceuticals for $2.6 billion  -  Feb 21, 2007
Pharma Times (subscription),Adderall XR sales in 2006 advanced 18% to $864 million, while the ADHD patch product Daytrana (methylphenidate), which was launched in the USA last June,

Shire to Buy New River for $2.6 Billion for Vyvanse (Update6)  -  Feb 20, 2007
BloombergVyvanse is one of three new attention deficit medicines Shire plans to introduce this year, in addition to Daytrana, the ADHD patch first marketed in June.

Shire to Buy New River for $2.6 Billion for Vyvanse (Update5)  -  Feb 20, 2007
BloombergVyvanse is one of three new attention deficit medicines Shire plans to introduce this year, including SPD-465 and Connexyn, in addition to Daytrana,

Shire to Buy New River Pharmaceuticals  -  Feb 20, 2007
Smartmoney.comIn addition to hyperactivity drugs Adderall XR and Daytrana, the Basingstoke, England-based company also sells Alzheimer's disease treatment Reminyl and

Shire Agrees to Acquire New River to Gain Full Control of VYVANSE ...  -  Feb 20, 2007
Earthtimes.orgShire has a leading position in the US ADHD market with ADDERALL XR and DAYTRANA(TM), and also has two additional products in registration; SPD465 (high

Costs to rise on 5 drugs through Tricare  -  18 Jan 2007
NavyTimes.com,On March 21, antifungal medication Vusion will move to Tier 3, and April 18, ADHD medications Focalin, Focalin XR and the Daytrana patch will also move to

Analyst initiations 12-29-06: Pharmaceuticals Noven & Pozen take ...  -  Dec 29, 2006
Blogging StocksBaird initiated Noven Pharmaceuticals (NASDAQ: NOVN) with an Outperform and $30 target, based on the Daytrana, which Baird believes should be a driver for

Investing in Small Cap Pharmaceuticals: Noven, Barrier, Penwest ...  -  Jan 8, 2007
Seeking Alpha,In the case of Noven, they had the approval and the launch of the Daytrana patch. That's the first ritalin patch for the treatment of attention deficit

Noven Provides Update on Daytrana Methylphenidate Transdermal System  -  Nov 29, 2006
PharmaLive.com (press release),Methylphenidate, the active ingredient in Daytrana(TM), is a Schedule II controlled substance regulated by the DEA. Manufacturers of products containing

Noven says US DEA to allow extra Daytrana output  -  Nov 28, 2006
ReutersNoven said the additional sales of Daytrana, which is made by Noven and sold by Shire Plc (SHP.L: Quote, Profile, Research), are not expected to

Noven Pharmaceuticals (NOVN) Updates Production and Prescription ...  -  Nov 28, 2006
StreetInsider.com (subscription),Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) provided an update on production and prescription information related to its Daytrana methylphenidate transdermal

Noven says US DEA to allow extra Daytrana output  -  Nov 29, 2006
Therapeutics Daily (subscription) (press release),Noven said the additional sales of Daytrana, which is made by Noven and sold by Shire Plc, are not expected to meaningfully increase its fourth quarter

Noven Gets OK to Boost Methylphenidate  -  Nov 28, 2006
Houston Chronicle,Noven had been seeking permission to raise its production of the controlled substance in order to meet increased demand for Daytrana.

S&P Keeps Hold on Dell Shares  -  Dec 15, 2006
BusinessWeek...both for attention-deficit hyperactivity disorder (ADHD), and strong demand for recently launched Daytrana for ADHD and Elaprase for Hunter syndrome.

Market Report -- In Play (NOVN)  -  Nov 29, 2006
MSN MoneyNoven Pharma provides update on Daytrana methylphenidate transdermal system Co announces that the DEA has granted Noven additional methylphenidate quota for

Gulp! Down the hatch  -  Dec 12, 2006
Reading Eagle,Another example is a patch for ADHD in children called Daytrana (metylphenidate). There are other routes of administration of drugs not cataloged here as

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional